Brief: Alpha Tau Medical Reports Q1 Net Loss Per Share Of $0.12
23/05/2023 22:25
May 23 (Reuters) - Alpha Tau Medical Ltd DRTS.O :
* ALPHA TAU MEDICAL ANNOUNCES FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* ALPHA TAU MEDICAL LTD - CASH, CASH EQUIVALENTS & DEPOSITS
BALANCE OF $100.5 MILLION WITH RUNWAY OF AT LEAST TWO YEARS
* ALPHA TAU MEDICAL LTD - QTRLY NET LOSS PER SHARE, BASIC
AND
DILUTED $0.12
Source text for Eikon: ID:nGNX52tmTj
Further company coverage: DRTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Tau Medical
See all newsBrief: Alpha Tau Completes Patient Enrollment In Its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal Of FDA Approval Of Alpha Dart® To Treat Recurrent Cutaneous Squamous Cell Carcinoma
Brief: Alpha Tau Announces 100% Local Disease Control Rate And Favorable Safety Profile Observed In Alpha Dart® Pancreatic Cancer Trials Presented At Ddw 2026
Brief: Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing
Brief: Alpha Tau Announces First-Ever Oral Presentation Of Alpha Dart® Pancreatic Cancer Data At Digestive Disease Week (Ddw) 2026
Brief: Alpha Tau Medical Receives Japanese Marketing Approval For Alpha Dart In Head And Neck Cancer